Zhansheng Wu | Enzyme immobilization | Best Researcher Award

Posted on by ScienceFather

Prof. Zhansheng Wu | Enzyme immobilization | Best Researcher Award

Professor at  Xi’an Polytechnic University, China

🌟 Dr. Zhansheng Wu is a Vice President of the School of Environmental and Chemical Engineering at Xi’an Polytechnic University. 📚 A third-level professor, doctoral supervisor, and renowned scientist, he has led prestigious projects under China’s National Natural Science Foundation and the National Key R&D Program. 🌏 Recognized globally, he is among the top 2% of scientists worldwide and serves as an editorial board member of Biochar and Carbon Research. His contributions center around clean ecological dyeing, biological and environmental chemical industries, and material sciences.

Professional Profiles:

orcid

Education🎓 

2017.4–2017.5: University of California, Los Angeles – Study. 2015.12–2016.5: University of Turin – Visiting Scholar. 2008.8–2011.6: Beijing Institute of Technology – Doctorate in Biochemistry  2003.8–2006.6: Shihezi University – Master’s in Food Science & Engineering  1999.8–2003.6: Shihezi University – Bachelor’s in Food Science & Engineering.

Experience🛠️ 

Vice President and Professor, Xi’an Polytechnic University.  Chief Scientist of Shaanxi Province’s “Qin Chuangyuan” team  Project Leader for National Key Research & Development Plan (2021–2024). Editorial Board Member for Biochar and Carbon Research. Visiting Scholar, University of Turin (2015–2016).

Awards and Honors🏅

Approved by National Natural Science Foundation of China – Young Talents Fund.  Listed in the Top 100,000 Scientists and Top 2% globally.  Leader of Shaanxi’s “Qin Chuangyuan” Scientist + Engineer Team. Published in top journals like Chemical Engineering Journal (IF > 16.7).

Research Focus🔍

Clean ecological dyeing and finishing technologies.  Development of biochar-based bactericide systems for soil improvement. Photocatalysis for environmental remediation and water treatment. Sustainable agricultural practices with biochar innovations. Exploring chemical-material industry advancements.

✍️Publications Top Note :

  • Biochar and Environmental Applications:
    • Prediction of biochar yield and specific surface area using advanced algorithms.
    • Multi-functional biochar composites for pollution control and fertilizer applications.
  • Metal-Organic Frameworks (MOFs):
    • Amino-functionalized MOFs for enzyme stability and organic pollutant degradation.
    • Hollow MOFs designed for enzyme immobilization and rare ginsenoside synthesis.
  • Photocatalysis and Functional Materials:
    • Development of heterojunction photocatalysts for efficient degradation of pollutants.
    • N-doped Ti3C2Tx-MXene-modified photocatalysts for enhanced photocatalytic ammonia synthesis.
  • Biocontrol and Environmental Microbiology:
    • Identification and genetic characterization of biocontrol strains with siderophilic properties.
    • Bioreduction of hexavalent chromium using Bacillus subtilis enhanced with humic acid.
  • Innovative Enzyme Immobilization:
    • Enhancements in enzyme loading and activity for industrial pollutant degradation.
  • Nanomaterials and Wastewater Treatment:
    • Strategies leveraging BaTiO3 piezocatalysis for vibration energy harvesting and water purification.
    • Functionalized ZnO/ZnSe composites for organic dye wastewater treatment.
  • Agricultural and Environmental Stress:
    • Applications of microcapsules for Capsicum growth under salt stress.

Conclusion

Zhansheng Wu stands as a stellar candidate for the Best Researcher Award due to his groundbreaking work in environmental chemical engineering and materials science. His extensive contributions to sustainable technologies, particularly in photocatalysis and biochar systems, have significantly advanced global environmental goals. While there is room to enhance the societal impact and commercialization aspects of his research, his academic excellence, leadership in high-value projects, and international recognition firmly establish him as a deserving contender for this prestigious award.

A F M Motiur Rahman | Bio-chemicals | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr A F M Motiur Rahman | liquidos ionicos | Best Researcher Award

Associate Professor at Pharmaceutical Chemistry, Saudi Arabia

A dedicated pharmaceutical scientist, Assoc. Prof. Dr A F M Motiur Rahman holds a Ph.D. from Yeungnam University, South Korea, with a strong foundation in medicinal chemistry, particularly in synthetic molecule design and drug metabolism. Serving as an Associate Professor at King Saud University, Saudi Arabia, he leads research in synthetic molecule development for anticancer applications, mentoring students across various academic levels. His work encompasses innovative synthesis and bio-conjugate chemistry, advancing cancer drug discovery through ongoing projects and published articles.

Publication Profile

scopus

orcid

Education 🏅

Ph.D. in Pharmaceutical Science, Yeungnam University, South Korea, 2007M.Sc. in Organic Chemistry, University of Rajshahi, Bangladesh, 2002B.Sc. in Chemistry (Honors), University of Rajshahi, Bangladesh, 2000H.S.C. in Science, Rajshahi Education Board, Bangladesh, 1995S.S.C. in Science, Rajshahi Education Board, Bangladesh, 1993

Experience 👩‍🏫

Currently an Associate Professor at King Saud University,Assoc. Prof. Dr A F M Motiur Rahman has also served as Assistant Professor, Postdoctoral Research Associate at Kyungpook National University, and Research Professor at Yeungnam University. He’s contributed to Frontiers in Chemistry and the Malaysian Journal of Medical and Biological Research, specializing in heterocyclic chemistry, chromatographic analysis, and organic molecule synthesis.

Awards and Honors 🏆

Recipient of esteemed scholarships including NEDO Fellowship (Japan), BK21 Scholarship (South Korea), and multiple Korea Research Foundation Fellowships, Assoc. Prof. Dr A F M Motiur Rahman  has received numerous recognitions, such as the Yeungnam University Ph.D. Scholarship, reflecting his impactful contributions to pharmaceutical chemistry and organic molecule synthesis.

Research Focus 🔬

Specializing in anticancer agents, Assoc. Prof. Dr A F M Motiur Rahman  leads research in synthesizing bioactive molecules, focusing on enzyme inhibitory activities, topoisomerase inhibition, and bio-conjugate chemistry. His projects emphasize metabolic profiling of synthesized molecules, advancing anticancer drug discovery through the design of synthetic and natural compounds for targeted therapies.

Publication  Top Notes

DNA-binding and Anticancer Research

Title: Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes

Journal: Journal of Molecular Structure, 2025, 1321, Article 140044

Authors: Zhang, D., Li, M., Rahman, A.F.M.M., Liu, Z., Lu, Y.

Citations: 0

Multitarget Anticancer Agents

Title: Synthesis and Evaluation of Thiazolyl-indole-2-carboxamide Derivatives as Potent Multitarget Anticancer Agents

Journal: ACS Omega, 2024, 9(40), Pages 41944–41967

Authors: Saadan, N.M., Ahmed, W.U., Kadi, A.A., Al-Wabli, R.I., Rahman, A.F.M.M.

Citations: 0

Dual Inhibition in Cancer Therapy

Title: Design, synthesis, and mechanistic evaluation of novel benzimidazole-hydrazone compounds as dual inhibitors of EGFR and HER2

Journal: Journal of Molecular Structure, 2024, 1309, Article 138177

Authors: Mirgany, T.O., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 1

Antibacterial Compound Discovery

Title: New antibacterial penicimenolide G with unusual 12-membered resorcylic acid lactone ring isolated from Aspergillus giganteus

Journal: Phytochemistry Letters, 2024, 62, Pages 18–23

Authors: Shamim, A.H.M., Mondol, M.A.M., Hossain, M., Alharbi, H.A., Rahman, A.F.M.M.

Citations: 0

Multi-Kinase Inhibitors Development

Title: Discovery of 1H-benzo[d]imidazole-(halogenated)benzylidenebenzohydrazide Hybrids as Potential Multi-Kinase Inhibitors

Journal: Pharmaceuticals, 2024, 17(7), Article 839

Authors: Mirgany, T.O., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 0

Anticancer Photophysical Studies

Title: Synthesis, Cytotoxicity, and Photophysical Investigations of 2-Amino-4,6-diphenylnicotinonitriles

Journal: Molecules, 2024, 29(8), Article 1808

Authors: Al-Ghamdi, A.R., Rahman, S., Al-Wabli, R.I., Al-Mutairi, M.S., Rahman, A.F.M.M.

Citations: 0

Solar Cell Efficiency

Title: The photon-electrical conversion efficiency of dye-sensitive solar cells fabricated using silver-nanoparticle/titania photocathode

Journal: Applied Research, 2024, 3(1), Article e202300044

Authors: Daniel, L.S., Kaffer, R.T., Kalipi, L.M., Kalengay, M., Uahengo, V.

Citations: 0

Nano Drug Delivery System for Brain

Title: Phospholipid-based nano drug delivery system of curcumin using MSP1D1 protein and poloxamer 407

Journal: Journal of Nanoparticle Research, 2024, 26(1), Article 12

Authors: Shariare, M.H., Mannan, M., Khan, F., Uddin, M.N., Kazi, M.

Citations: 2

Pyrrolo[2,3-d]pyrimidine Kinase Inhibitors

Title: Discovery of New Pyrrolo[2,3-d]pyrimidine Derivatives as Potential Multi-Targeted Kinase Inhibitors and Apoptosis Inducers

Journal: Pharmaceuticals, 2023, 16(9), Article 1324

Authors: Alotaibi, A.A., Alanazi, M.M., Rahman, A.F.M.M.

Citations: 4

Selective Kinase Inhibition

Title: Novel pyrrolo[2,3-d]pyrimidine derivatives as multi-kinase inhibitors with VEGFR-2 selectivity

Journal: Journal of Saudi Chemical Society, 2023, 27(5), Article 101712

Authors: Alotaibi, A.A., Asiri, H.H., Rahman, A.F.M.M., Alanazi, M.M.

Citations: 10

Conclusion

Given the candidate’s robust academic qualifications, international research experience, successful mentorship, and strong track record in pharmaceutical and organic chemistry research, they are exceptionally suited for the Best Researcher Award. Their commitment to teaching, funding acquisition, and contributions to therapeutic compound development mark them as a distinguished researcher who has made impactful contributions to the field. Further engagement in publishing and interdisciplinary initiatives could enhance their already strong candidacy, positioning them as a future leader in pharmaceutical chemistry and organic synthesis.

Prof Dr. Xinwu Lu | Biomedicine | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Xinwu Lu | Biomedicine | Best Researcher Award

Prof Dr. Xinwu Lu, Shanghai Ninth People’s Hospital, Shanghai JiaoTong University School of Medicine, China

Dr. Xinwu Lu, MD, Ph.D., is a distinguished Professor of Vascular Surgery and Chief Surgeon at the Department of Vascular Surgery, Shanghai Ninth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine. With extensive training from Shanghai Jiao Tong University and Amsterdam University Medical Centres, he is renowned for his expertise in vascular surgery and epidemiology. Dr. Lu holds key leadership roles including Chairman of the Shanghai Jiao Tong University Vascular Disease Forum and Director of the Vascular Disease Center. He has authored over 200 papers, holds 41 patents, and serves on numerous editorial boards, impacting vascular surgery globally with a focus on innovative medical solutions.

Professional Profiles:

Scopus

🎓 Education and Training

Shanghai Jiao Tong University School of Medicine, ChinaM.D. (1998) – Vascular SurgeryPh.D. (2004) – Vascular SurgeryAmsterdam University Medical Centres, NetherlandsVisiting Scholar (2005) – Epidemiology, Vascular SurgeryLeipzig University, GermanyVisiting Scholar (2013) – Vascular Surgery

🏅 Leadership Roles and Professional Memberships

Chairman, Shanghai Jiao Tong University Vascular Disease Forum (SJVF)Director, Shanghai Jiao Tong University Vascular Disease CenterFirst Vice President, Vascular Surgery Committee of Shanghai Medical AssociationFirst Vice President, Vascular Surgery Committee of Shanghai Physicians AssociationPresident, Vascular Malformations Committee of Chinese Medical Doctor AssociationPresident, Vascular Malformations Committee of Traditional Chinese Medicine AssociationPresident, Peripheral Vascular Committee of Chinese Medicine Intervention AssociationMember, The American Society for Vascular Surgery (SVS)Member, The European Society for Vascular Surgery (ESVS)

📚 Editorial and Reviewer Roles

Editorial board member and reviewer for 14 SCI journals (including AVS, Biomaterials, JVS, EJVES, etc.)Reviewer for 10 Chinese journals (including Chinese Medical Journal, Chinese Journal of Surgery, Chinese Journal of General Surgery, Chinese Journal of Experimental Surgery, etc.)

👨‍⚕️ Professional Positions

1998 – 2004: Attending Doctor, Department of Vascular Surgery, Shanghai Ninth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

✍️Publications Top Note :

Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway

Authors: Chen, K., Jin, H.-J., Wu, Z.-H., Lu, X.-W., Zheng, X.-T.
Journal: Molecular Medicine, 2024, 30(1), 58

Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with venous thromboembolism: protocol of a systematic review and meta-analysis

Authors: Fu, Y., Pu, H., Wang, Y., Hu, M., Cheng, Y.
Journal: BMJ Open, 2024, 14(3), e074547

Drug-coated balloon therapy for in-stent restenosis in patients with iliofemoral deep vein thrombosis: A single-arm observational study

Authors: Lei, J., Pu, H., Zhang, L., Wang, R., Lu, X.
Journal: Catheterization and Cardiovascular Interventions, 2024, 103(5), pp. 752–757

Integrative multi-omics analyses reveal vesicle transport as a potential target for thoracic aortic aneurysm

Authors: Lei, J., Qiu, P., Wu, Z., Xu, Z., Lu, X.
Journal: Computers in Biology and Medicine, 2024, 170, 108071

Dynamin-related protein 1 mediates the therapeutic effect of isoliquiritigenin in diabetic intimal hyperplasia via regulation of mitochondrial fission

Authors: Zhang, B.-F., Wu, Z.-H., Chen, K., Lu, X.-W., Zheng, X.-T.
Journal: Hypertension Research, 2024

Clinical efficacy of sodium aescinate administration following endovenous laser ablation for varicose veins

Authors: Yang, X., Jin, J., Huang, S., Ye, K., Lu, X.
Journal: Vascular, 2024

Development and validation of a nomogram for identifying venous thromboembolism following oral and maxillofacial oncological surgery with simultaneous reconstruction

Authors: Wang, X., Chen, S., Sun, L., Lu, X., Ding, A.
Journal: European Journal of Surgical Oncology, 2024, 50(1), 107307

CDKN2B-AS1 mediates proliferation and migration of vascular smooth muscle cells induced by insulin

Authors: Jin, H.-J., Wu, Z.-H., Zhang, B.-F., Wang, W.-T., Zheng, X.-T.
Journal: Cell and Tissue Research, 2023, 394(3), pp. 455–469

Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis

Authors: Pu, H., Song, J., He, Z., Lu, X., Liu, G.
Journal: Thrombosis Journal, 2023, 21(1), 96

An H2S-BMP6 Dual-Loading System with Regulating Yap/Taz and Jun Pathway for Synergistic Critical Limb Ischemia Salvaging Therapy

Authors: Hu, J., Xu, Z., Liao, D., Liu, X., Li, B.
Journal: Advanced Healthcare Materials, 2023, 12(28), 2301316